Rubric Capital Management (New York)’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108M | Buy |
|
|||||
|
2025
Q1 | $75.1M | Buy |
|
|||||
|
2024
Q4 | $51.8M | Buy |
|
|||||
|
2024
Q3 | $60.5M | Hold |
|
|||||
|
2024
Q2 | $45.2M | Buy |
|
|||||
|
2024
Q1 | $43.3M | Sell |
|
|||||
|
2023
Q4 | $51M | Sell |
|
|||||
|
2023
Q3 | $53.5M | Sell |
|
|||||
|
2023
Q2 | $47.6M | Buy |
|
|||||
|
2023
Q1 | $29.9M | Buy |
|
|||||
|
2022
Q4 | $23.5M | Buy |
|
|||||
|
2022
Q3 | $18.6M | Buy |
|
|||||
|
2022
Q2 | $5.07M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.75M | Buy |
|